Kronik Prostatitler ve Erektil Disfonksyon İlişkisi
Synopsis
Erectile dysfunction (ED) and chronic prostatitis / chronic pelvic pain syndrome (CP/CPPS) are two major urological entities that particularly affect the reproductive and active male population, leading to severe psychosocial morbidity and dramatically reducing the quality of life. While ED is a multifactorial pathology with vascular, hormonal, neurological, and psychogenic components, the local inflammation, pelvic floor neuromuscular dysfunction, and chronic pain cycle developing on the grounds of chronic prostatitis directly trigger these mechanisms. Epidemiological studies reveal that the prevalence of ED in cases with CP/CPPS ranges within a remarkably wide and high interval of 15.1% to 48%; this condition is statistically significantly higher, especially in the young male population, compared to the healthy general population. The relationship between these two entities is based on shared mechanisms such as disruptions in nitric oxide pathways, pelvic sympathetic hyperexcitability, pudendal nerve irritation, and psychogenic anxiety triggered by chronic pain. In this section, the relationship between chronic prostatitis and ED is comprehensively analyzed in light of international guidelines and current literature, accompanied by molecular pathophysiological bridges, the clinical correlation of international questionnaire scores (NIH-CPSI and IIEF), concomitant ejaculatory dysfunctions, and the management of urogenital flora.
References
Nickel JC, Elhilali M, Vallancien G. Benign prostatic hyperplasia (BPH) and prostatitis: prevalence of painful ejaculation in men with clinical BPH. BJU Int. 2005;95(4):571-4.
Minhas S, Bettocchi C, Boeri L, Capogrosso P, Carvalho J, Cilesiz NC, et al. European association of urology guidelines on male sexual and reproductive health: 2021 update on male infertility. European urology. 2021;80(5):603-20.
Sansone A, Mollaioli D, Limoncin E, Ciocca G, Bắc NH, Cao TN, et al. The Sexual Long COVID (SLC): Erectile Dysfunction as a Biomarker of Systemic Complications for COVID-19 Long Haulers. Sexual Medicine Reviews. 2022;10(2):271-85.
Healy R, Thorne C, Manjunath A. Chronic prostatitis (chronic pelvic pain syndrome). BMJ. 2023;383:e073908.
Polackwich A, Shoskes D. Chronic prostatitis/chronic pelvic pain syndrome: a review of evaluation and therapy. Prostate Cancer and Prostatic Diseases. 2016;19(2):132-8.
Chen X, Hu C, Peng Y, Lu J, Yang N, Chen L, et al. Association of diet and lifestyle with chronic prostatitis/chronic pelvic pain syndrome and pain severity: a case–control study. Prostate Cancer and Prostatic Diseases. 2016;19(1):92-9.
Dias NC. High Density Surface Electromyography For The Assessment of Pelvic Floor Dysfunction: University of Houston; 2020.
Gürel A, Çoşğun İG. The Evaluation of Benign Prostate Hyperplasia and Chronic Prostatitis Symptoms with Obstructive Sleep Apnea Syndrome Patients. Osmangazi Tıp Dergisi. 2025;47(2):186-92.
Kloner RA, Burnett AL, Miner M, Blaha MJ, Ganz P, Goldstein I, et al. Princeton IV consensus guidelines: PDE5 inhibitors and cardiac health. J Sex Med. 2024;21(2):90-116.
Li HJ, Kang DY. Prevalence of sexual dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome: a meta-analysis. World J Urol. 2016;34(7):1009-17.
Doiron RC, Nickel JC. Chronic prostatitis/chronic pelvic pain syndrome. Urologic Principles and Practice: Springer; 2020. p. 287-302.